Exclusion of older adults from clinical trials in cancer-related pain
- PMID: 35991635
- PMCID: PMC9385985
- DOI: 10.3389/fmed.2022.945481
Exclusion of older adults from clinical trials in cancer-related pain
Abstract
Pain is one of the most common symptoms in cancer patients including older adults. The objective of this study was to evaluate the enrollment criteria that can limit the inclusion of older adults in clinical trials concerning cancer-related pain (CRP). The study included 356 trials registered with ClinicalTrials.gov. Our primary outcome measures were the proportion of trials that excluded patients based on upper age limits (80 years of age or less), strict organ-specific exclusion criteria, broad and imprecise criteria, and inadequate performance score. One hundred and twenty-six trials (35.4%) had upper age limits. Strict exclusion criteria were used in 95 (26.7%) trials. Broad and imprecise exclusion criteria were listed in 57 (16.2%) trials. Low performance score was used as an exclusion criterion in 4 trials (1.1%). Overall, in 241 trials (67.7%) there was either an upper age limit or at least one strict or broad and imprecise exclusion criterion, or a criterion involving the performance status. The odds of excluding older adults were significantly higher in certain neoplasm types, study objectives, intervention types, and center locations. In conclusion, considerable proportion of recent clinical trials concerning CRP either explicitly exclude older adults or create high risk of such exclusion which substantially limits the evidence base for the treatment of such patients in clinical practice. Sponsors and investigators should consider careful modification of the enrollment criteria to improve the inclusion of older individuals who make up the major proportion of cancer patients population.
Keywords: cancer pain; cancer-related pain; clinical trial; elderly; enrollment criteria; older adults.
Copyright © 2022 Krysa, Kowalczyk, Borysowski, Lachota and Pasierski.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Exclusion of older patients from randomized clinical trials in Parkinson's disease.Geroscience. 2024 Aug;46(4):3819-3830. doi: 10.1007/s11357-024-01104-4. Epub 2024 Feb 23. Geroscience. 2024. PMID: 38396125 Free PMC article.
-
Eligibility criteria in clinical trials in breast cancer: a cohort study.BMC Med. 2023 Jul 3;21(1):240. doi: 10.1186/s12916-023-02947-y. BMC Med. 2023. PMID: 37400830 Free PMC article.
-
Exclusion of older adults from randomized controlled trials in rheumatoid arthritis.Rheumatology (Oxford). 2024 Mar 1;63(3):672-679. doi: 10.1093/rheumatology/kead257. Rheumatology (Oxford). 2024. PMID: 37243691
-
Representation of older adults in randomized controlled trials on systemic treatment in plaque psoriasis: A systematic review.J Am Acad Dermatol. 2020 Aug;83(2):412-424. doi: 10.1016/j.jaad.2019.07.079. Epub 2019 Jul 29. J Am Acad Dermatol. 2020. PMID: 31369769
-
Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis: A Systematic Review.JAMA Dermatol. 2020 Nov 1;156(11):1240-1245. doi: 10.1001/jamadermatol.2020.2940. JAMA Dermatol. 2020. PMID: 32822481
Cited by
-
Impact of COVID-19 pandemic on older cancer patients: Proposed solution by the International Geriatric Radiotherapy Group.Front Oncol. 2023 Mar 7;13:1091329. doi: 10.3389/fonc.2023.1091329. eCollection 2023. Front Oncol. 2023. PMID: 36959795 Free PMC article.
-
Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group.Cancers (Basel). 2023 Oct 13;15(20):4981. doi: 10.3390/cancers15204981. Cancers (Basel). 2023. PMID: 37894347 Free PMC article.
-
Exclusion of older patients from randomized clinical trials in Parkinson's disease.Geroscience. 2024 Aug;46(4):3819-3830. doi: 10.1007/s11357-024-01104-4. Epub 2024 Feb 23. Geroscience. 2024. PMID: 38396125 Free PMC article.
-
Eligibility criteria in clinical trials in breast cancer: a cohort study.BMC Med. 2023 Jul 3;21(1):240. doi: 10.1186/s12916-023-02947-y. BMC Med. 2023. PMID: 37400830 Free PMC article.
References
-
- Nadler MB, Desnoyers A, Langelier DM, Amir E. The effect of exercise on quality of life, fatigue, physical function, and safety in advanced solid tumor cancers: a meta-analysis of randomized control trials. J Pain Symptom Manage. (2019) 58:899–908.e7. 10.1016/j.jpainsymman.2019.07.005 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous